Guided Therapeutics (GTHP) Short Interest Ratio & Short Volume $0.14 +0.01 (+5.00%) As of 01/21/2025 01:06 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartEarningsFinancialsSEC FilingsShort Interest Guided Therapeutics Short Interest DataGuided Therapeutics (GTHP) has a short interest of 7,800 shares. This marks a ∞ increase in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 7,857 shares to cover all short positions.Current Short Interest7,800 sharesPrevious Short Interest0 sharesChange Vs. Previous Month+∞Dollar Volume Sold Short$1,170.00Short Interest Ratio0.2 Days to CoverLast Record DateDecember 31, 2024Outstanding Shares65,290,000 sharesPercentage of Shares Shorted0.01%Today's Trading Volume5,001 sharesAverage Trading Volume7,857 sharesToday's Volume Vs. Average64% Short Selling Guided Therapeutics? Sign up to receive the latest short interest report for Guided Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGTHP Short Interest Over TimeGTHP Days to Cover Over TimeGTHP Percentage of Float Shorted Over Time Guided Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/31/20247,800 shares $1,170.00 No ChangeN/A0.2 $0.15 11/15/2024400 shares $68.00 -96.7%N/A0 $0.17 10/31/202412,000 shares $2,400.00 -2.4%N/A0.2 $0.20 10/15/202412,300 shares $1,723.23 -6.1%N/A4.7 $0.14 9/30/202413,100 shares $2,292.50 +36.5%N/A1.4 $0.18 9/15/20249,600 shares $1,824.00 +146.2%N/A1 $0.19 8/31/20243,900 shares $538.20 +1,200.0%N/A0.3 $0.14 8/15/2024300 shares $35.37 -72.7%N/A0 $0.12 7/31/20241,100 shares $132.00 -38.9%N/A0.1 $0.12 7/15/20241,800 shares $239.28 No ChangeN/A0 $0.13 Get the Latest News and Ratings for GTHP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Guided Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 6/15/20242,000 shares $280.00 -52.4%N/A0 $0.14 5/31/20244,200 shares $420.00 -71.0%N/A0.2 $0.10 5/15/202414,500 shares $1,160.00 +137.7%N/A0.1 $0.08 4/30/20246,100 shares $664.90 -77.2%N/A0.5 $0.11 4/15/202426,700 shares $2,563.20 +256.0%N/A0.9 $0.10 3/31/20247,500 shares $866.25 No ChangeN/A0.2 $0.12 2/29/20246,400 shares $918.40 +392.3%N/A0.1 $0.14 2/15/20241,300 shares $187.33 No ChangeN/A0 $0.14 1/15/20241,300 shares $184.60 No ChangeN/A0.1 $0.14 12/31/20231,300 shares $199.55 -45.8%N/A0 $0.15 12/15/20232,400 shares $453.60 +242.9%N/A0.1 $0.19 11/30/2023700 shares $94.50 -70.8%N/A0 $0.14 11/15/20232,400 shares $323.40 -64.2%N/A0.1 $0.13 10/31/20236,700 shares $1,005.00 No ChangeN/A0.2 $0.15 9/15/20234,900 shares $686.00 -53.8%N/A0.3 $0.14 8/31/202310,600 shares $1,590.00 -33.8%N/A0.2 $0.15 8/15/202316,000 shares $2,161.60 -0.6%N/A0.6 $0.14 7/31/202316,100 shares $2,334.50 +26.8%N/A0.7 $0.15 7/15/202312,700 shares $2,667.00 +32.3%N/A1.3 $0.21 6/30/20239,600 shares $2,160.00 +47.7%N/A0.2 $0.23 6/15/20236,500 shares $1,040.00 -55.5%N/A0 $0.16 5/31/202314,600 shares $2,774.00 +89.6%N/A1.2 $0.19 5/15/20237,700 shares $1,309.00 -56.7%N/A0.1 $0.17 4/30/202317,800 shares $4,272.00 +17,700.0%N/A0.8 $0.24 4/15/2023100 shares $28.00 -96.9%N/A0 $0.28 3/31/20233,200 shares $736.00 +18.5%N/A0.1 $0.23 3/15/20232,700 shares $796.23 +2,600.0%N/A0.9 $0.29 2/28/2023100 shares $29.00 -95.7%N/A0 $0.29 2/15/20232,300 shares $765.90 +76.9%N/A0.1 $0.33 1/31/20231,300 shares $450.32 No ChangeN/A0.1 $0.35Please take this warning seriously... (Ad)I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader in the country – in the next 30 days. In fact, I believe it could begin as soon as January 29th… Meaning you don’t have much time to prepare.Click here like your financial health depends on it. 12/30/20221,200 shares $360.00 -93.9%N/A0 $0.30 12/15/202219,500 shares $6,431.10 -21.4%N/A2.9 $0.33 11/30/202224,800 shares $8,665.12 +13.2%N/A2.5 $0.35 11/15/202221,900 shares $6,132.00 +10.6%N/A1 $0.28 10/31/202219,800 shares $5,940.00 -2.0%N/A0.8 $0.30 10/15/202220,200 shares $9,090.00 -7.8%N/A3.5 $0.45 9/30/202221,900 shares $11,169.00 +10.6%N/A2.3 $0.51 9/15/202219,800 shares $10,543.50 No ChangeN/A2.8 $0.53 8/31/202219,800 shares $9,702.00 -1.5%N/A6.4 $0.49 8/15/202220,100 shares $11,658.00 +133.7%N/A2.4 $0.58 7/31/20228,600 shares $4,472.00 +855.6%N/A1 $0.52 7/15/2022900 shares $512.28 No ChangeN/A0 $0.57 6/15/2022900 shares $427.95 -76.3%N/A0.1 $0.48 5/31/20223,800 shares $1,938.00 +192.3%N/A0.1 $0.51 5/15/20221,300 shares $715.00 No ChangeN/A0.1 $0.55 3/31/2022300 shares $195.00 -83.3%N/A0 $0.65 3/15/20221,800 shares $918.00 +1,700.0%N/A0.2 $0.51 2/28/2022100 shares $52.50 No ChangeN/A0 $0.53 2/15/2022100 shares $62.50 No ChangeN/A0 $0.63 1/31/2022100 shares $60.00 -75.0%N/A0 $0.60 1/15/2022400 shares $240.00 +300.0%N/A0 $0.60 12/31/2021100 shares $58.02 No ChangeN/A0 $0.58 12/15/2021100 shares $64.94 No ChangeN/A0 $0.65 11/30/2021100 shares $67.50 -50.0%N/A0 $0.68 11/15/2021200 shares $114.02 +100.0%N/A0 $0.57 10/29/2021100 shares $57.00 No ChangeN/A0 $0.57 10/15/2021100 shares $54.00 No ChangeN/A0 $0.54 9/30/2021100 shares $55.99 -98.2%N/A0 $0.56 9/15/20215,400 shares $3,345.30 +17.4%N/A0.4 $0.62 8/31/20214,600 shares $2,529.54 +475.0%N/A0.2 $0.55 8/13/2021800 shares $410.16 +700.0%N/A0 $0.51 7/30/2021100 shares $59.00 -95.7%N/A0 $0.59 7/15/20212,300 shares $1,426.00 +35.3%N/A0.3 $0.62 6/30/20211,700 shares $1,071.00 +240.0%N/A0.2 $0.63 6/15/2021500 shares $331.30 +400.0%N/A0 $0.66 5/28/2021100 shares $59.25 No ChangeN/A0 $0.59 5/14/2021100 shares $64.00 -75.0%N/A0 $0.64 4/30/2021400 shares $276.04 No ChangeN/A0 $0.69 3/15/2021100 shares $75.00 -92.3%N/A0 $0.75 2/26/20211,300 shares $1,157.00 -81.4%N/A0 $0.89 2/12/20217,000 shares $3,500.00 -41.2%N/A0.3 $0.50 1/29/202111,900 shares $4,998.00 +5,850.0%N/A0.3 $0.42 1/15/202113,800 shares $5,533.80 +294.3%N/A0.2 $0.40 12/31/20206,600 shares $2,171.40 -52.2%N/A0.5 $0.33 12/15/202013,800 shares $2,497.80 +294.3%N/A0.2 $0.18 11/30/20203,500 shares $665.00 -78.7%N/A0.1 $0.19 11/15/202016,400 shares $4,608.40 +1,540.0%N/A0.6 $0.28 10/30/20201,000 shares $363.00 +11.1%N/A0.1 $0.36 10/15/2020900 shares $279.18 +125.0%N/A0.2 $0.31 9/30/2020400 shares $148.00 -91.8%N/A0.1 $0.37Please take this warning seriously... (Ad)I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader in the country – in the next 30 days. In fact, I believe it could begin as soon as January 29th… Meaning you don’t have much time to prepare.Click here like your financial health depends on it. 9/15/20204,900 shares $1,813.00 -70.8%N/A0.5 $0.37 GTHP Short Interest - Frequently Asked Questions What is Guided Therapeutics' current short interest? Short interest is the volume of Guided Therapeutics shares that have been sold short but have not yet been covered or closed out. As of December 31st, investors have sold 7,800 shares of GTHP short. Learn More on Guided Therapeutics' current short interest. Is Guided Therapeutics' short interest increasing or decreasing? Guided Therapeutics saw a increase in short interest in December. As of December 31st, there was short interest totaling 7,800 shares, an increase of ∞ from the previous total of 0 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Guided Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "medical equipment" compare to Guided Therapeutics: Nexalin Technology, Inc. (3.09%), Spectral AI, Inc. (12.63%), NeuroOne Medical Technologies Co. (0.26%), SurgePays, Inc. (2.75%), Precision Optics Co., Inc. (0.49%), Envoy Medical, Inc. (1.76%), Positron Co. (0.00%), IRIDEX Co. (2.39%), Microbot Medical Inc. (5.14%), Beyond Air, Inc. (1.61%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks. What does it mean to sell short Guided Therapeutics stock? Short selling GTHP is an investing strategy that aims to generate trading profit from Guided Therapeutics as its price is falling. GTHP shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Guided Therapeutics? A short squeeze for Guided Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GTHP, which in turn drives the price of the stock up even further. How often is Guided Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GTHP, twice per month. The most recent reporting period available is December, 31 2024. More Short Interest Resources from MarketBeat Related Companies Nexalin Technology Short Squeeze Spectral AI Short Squeeze NeuroOne Medical Technologies Short Squeeze SurgePays Short Squeeze Precision Optics Short Squeeze Envoy Medical Short Squeeze Positron Short Squeeze IRIDEX Short Squeeze Microbot Medical Short Squeeze Beyond Air Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:GTHP) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guided Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guided Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GTHP Stock Alerts